X7L

N-[6-(cyclopentylmethoxy)-1,3-benzothiazol-2-yl]-4-{[(1S,2S)-2-(dimethylamino)cyclohexyl]amino}-2-fluorobenzene-1-sulfonamide

Created:	2022-11-04
Last modified:	2023-04-12

Find Related PDB Entry
1 entries where X7L is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	72
Chiral Atom Count	2
Bond Count	76
Aromatic Bond Count	16

2D diagram of X7L

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[6-(cyclopentylmethoxy)-1,3-benzothiazol-2-yl]-4-{[(1S,2S)-2-(dimethylamino)cyclohexyl]amino}-2-fluorobenzene-1-sulfonamide
Systematic Name (OpenEye OEToolkits)	~{N}-[6-(cyclopentylmethoxy)-1,3-benzothiazol-2-yl]-4-[[(1~{S},2~{S})-2-(dimethylamino)cyclohexyl]amino]-2-fluoranyl-benzenesulfonamide
Formula	C₂₇ H₃₅ F N₄ O₃ S₂
Molecular Weight	546.72
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CN(C)C1CCCCC1Nc1ccc(c(F)c1)S(=O)(=O)Nc1nc2ccc(cc2s1)OCC1CCCC1
SMILES	CACTVS	3.385	CN(C)[CH]1CCCC[CH]1Nc2ccc(c(F)c2)[S](=O)(=O)Nc3sc4cc(OCC5CCCC5)ccc4n3
SMILES	OpenEye OEToolkits	2.0.7	CN(C)C1CCCCC1Nc2ccc(c(c2)F)S(=O)(=O)Nc3nc4ccc(cc4s3)OCC5CCCC5
Canonical SMILES	CACTVS	3.385	CN(C)[C@H]1CCCC[C@@H]1Nc2ccc(c(F)c2)[S](=O)(=O)Nc3sc4cc(OCC5CCCC5)ccc4n3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(C)[C@H]1CCCC[C@@H]1Nc2ccc(c(c2)F)S(=O)(=O)Nc3nc4ccc(cc4s3)OCC5CCCC5
InChI	InChI	1.06	InChI=1S/C27H35FN4O3S2/c1-32(2)24-10-6-5-9-22(24)29-19-11-14-26(21(28)15-19)37(33,34)31-27-30-23-13-12-20(16-25(23)36-27)35-17-18-7-3-4-8-18/h11-16,18,22,24,29H,3-10,17H2,1-2H3,(H,30,31)/t22-,24-/m0/s1
InChIKey	InChI	1.06	DYROPBGPVFEZHO-UPVQGACJSA-N

Related Resource References

Resource Name	Reference
PubChem	167488607

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.